ACETO Corp (NASDAQ: ACET) announced that Rising Pharmaceuticals, Inc., its generic finished dosage form subsidiary, has completed the purchase of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE